A detailed history of Macquarie Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Macquarie Group LTD holds 342,421 shares of LLY stock, worth $272 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
342,421
Previous 362,920 5.65%
Holding current value
$272 Million
Previous $329 Million 7.67%
% of portfolio
0.34%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $15.8 Million - $19.7 Million
-20,499 Reduced 5.65%
342,421 $303 Million
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $84.1 Million - $105 Million
-115,960 Reduced 24.21%
362,920 $329 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $63 Million - $84.4 Million
106,467 Added 28.59%
478,880 $373 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $6.37 Million - $7.51 Million
12,135 Added 3.37%
372,413 $217 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $133,018 - $183,385
306 Added 0.09%
360,278 $194 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $10.6 Million - $14.1 Million
-30,080 Reduced 7.71%
359,972 $169 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $44.5 Million - $52.3 Million
-143,293 Reduced 26.87%
390,052 $134 Million
Q4 2022

Feb 21, 2023

SELL
$321.55 - $374.67 $80.1 Million - $93.3 Million
-249,136 Reduced 31.84%
533,345 $195 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $128 Million - $146 Million
-431,015 Reduced 35.52%
782,481 $253 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $119 Million - $139 Million
-425,773 Reduced 25.97%
1,213,496 $393 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $833,384 - $1.04 Million
3,551 Added 0.22%
1,639,269 $469 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $86.7 Million - $108 Million
385,618 Added 30.85%
1,635,718 $452 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $2.75 Million - $3.38 Million
12,402 Added 1.0%
1,250,100 $289 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $147 Million - $190 Million
811,525 Added 190.42%
1,237,698 $284 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $6.51 Million - $8.43 Million
39,629 Added 10.25%
426,173 $79.6 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $836,118 - $1.11 Million
-6,409 Reduced 1.63%
386,544 $65.3 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $2.42 Million - $2.8 Million
-16,546 Reduced 4.04%
392,953 $58.2 Million
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $3.34 Million - $4.02 Million
-24,499 Reduced 5.64%
409,499 $67.2 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $2.71 Million - $3.35 Million
-22,766 Reduced 4.98%
433,998 $60.2 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $18.3 Million - $22.7 Million
171,558 Added 60.15%
456,764 $60 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $1.66 Million - $1.8 Million
-15,508 Reduced 5.16%
285,206 $31.9 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $145,245 - $169,538
-1,311 Reduced 0.43%
300,714 $33.3 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $7.52 Million - $8.85 Million
-67,576 Reduced 18.28%
302,025 $39.2 Million
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $5.07 Million - $5.68 Million
47,837 Added 14.87%
369,601 $42.8 Million
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $203,230 - $254,002
2,367 Added 0.74%
321,764 $34.5 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $2.7 Million - $3.1 Million
35,653 Added 12.57%
319,397 $27.3 Million
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $890 - $1,051
-12 Reduced -0.0%
283,744 $22 Million
Q4 2017

Feb 15, 2018

SELL
$81.94 - $87.89 $4.15 Million - $4.45 Million
-50,589 Reduced 15.13%
283,756 $24.1 Million
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $25.8 Million - $28.6 Million
334,345
334,345 $28.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.